Quest Diagnostics announced it will release its third quarter 2026 financial results on October 22, 2026, before the market opens. The company will hold a conference call at 8:30 a.m. Eastern Time to discuss the results, accessible via phone and webcast. Investors and interested parties can listen to a replay of the call until November 5, 2026. This earnings report will provide insights into the company's recent performance and outlook in the diagnostic services sector.
Quest Diagnostics shares are currently priced at USD 232.90 on Pluang, showing a 5.51% decline in the last day. The stock holds a market cap of $27.03 billion and a dividend yield of 1.4%, with all recent Pluang orders being buys. These figures are as of September 23, 2026, 03:32 WIB.
